Description

On episode #57 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 6/6 – 6/19/24.

Host: Daniel Griffin

Subscribe (free): Apple Podcasts, RSS, email

Become a patron of Puscast!

Links for this episode

• Viral
• Is letermovir or valganciclovir better to prevent CMV in kidney transplant recipients (JID)
• CMV antiviral therapy (GoodRx)
• Prevalence of and risk for CMV reactivation during COVID-19 pneumonia (PLoS One)
• Sofosbuvir off-label yellow fever treatment (OFID)
  Bacterial
• Preventing resistant gram negative bacteria through beta-lactam de-escalation in sepsis patients (CID)
• Competing risk analysis, survival analysis that aims to correctly estimate marginal probability of an event (Columbia University)
• Continuous or intermittent b-lactam infusion for critical sepsis (JAMA Network)
• Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock (JAMA Network)
• Phoenix sepsis score and risk in children with cancer (JAMA Network)
• New recognized spotted fever group Rickettsia in Northern California (Emerging Infectious Diseases)
• Screening for mycobacterium tuberculosis (Transplant Infectious Disease)
  Fungal
• Potential sexual transmission of Tinea pubogenitalis from TMWII (JAMA Dermatology)
• Household transmission of tinea infection (OFID)
• Drug-resistant oral candidiasis in HIV infected patients (BMC Infectious Disease)
  Parasitic
• Handheld digital microscope for rapid and comprehensive screening for urogenital and gastrointestinal schistosomiasis (American Journal of Tropical Medicine and Hygiene)
• Scorecard approach to eliminate onchocerciasis (Am J Trop Med Hyg)
  Miscellaneous
• Association between antibiotic receipt and provider rating (OFID)
• Infectious diseases and infection control prevention strategies when on ECMO (Perfusion)

Music is by Ronald Jenkees